348 related articles for article (PubMed ID: 32733460)
21. Gut Microbiome, Short-Chain Fatty Acids, and Mucosa Injury in Young Adults with Human Immunodeficiency Virus Infection.
Qing Y; Xie H; Su C; Wang Y; Yu Q; Pang Q; Cui F
Dig Dis Sci; 2019 Jul; 64(7):1830-1843. PubMed ID: 30560340
[TBL] [Abstract][Full Text] [Related]
22. Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study.
Harbison JE; Roth-Schulze AJ; Giles LC; Tran CD; Ngui KM; Penno MA; Thomson RL; Wentworth JM; Colman PG; Craig ME; Morahan G; Papenfuss AT; Barry SC; Harrison LC; Couper JJ
Pediatr Diabetes; 2019 Aug; 20(5):574-583. PubMed ID: 31081243
[TBL] [Abstract][Full Text] [Related]
23. Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors.
de la Cuesta-Zuluaga J; Mueller NT; Álvarez-Quintero R; Velásquez-Mejía EP; Sierra JA; Corrales-Agudelo V; Carmona JA; Abad JM; Escobar JS
Nutrients; 2018 Dec; 11(1):. PubMed ID: 30591685
[TBL] [Abstract][Full Text] [Related]
24. New strain of
Jiang XW; Li YT; Ye JZ; Lv LX; Yang LY; Bian XY; Wu WR; Wu JJ; Shi D; Wang Q; Fang DQ; Wang KC; Wang QQ; Lu YM; Xie JJ; Li LJ
World J Gastroenterol; 2020 Oct; 26(40):6224-6240. PubMed ID: 33177795
[TBL] [Abstract][Full Text] [Related]
25. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease.
Aho VTE; Houser MC; Pereira PAB; Chang J; Rudi K; Paulin L; Hertzberg V; Auvinen P; Tansey MG; Scheperjans F
Mol Neurodegener; 2021 Feb; 16(1):6. PubMed ID: 33557896
[TBL] [Abstract][Full Text] [Related]
26. Orthopedic Surgery Causes Gut Microbiome Dysbiosis and Intestinal Barrier Dysfunction in Prodromal Alzheimer Disease Patients: A Prospective Observational Cohort Study.
Liu F; Duan M; Fu H; Zhao G; Han Y; Lan F; Ahmed Z; Cao G; Li Z; Ma D; Wang T
Ann Surg; 2022 Aug; 276(2):270-280. PubMed ID: 35766370
[TBL] [Abstract][Full Text] [Related]
27. Our Evolving Understanding of Kawasaki Disease Pathogenesis: Role of the Gut Microbiota.
Kaneko K; Akagawa S; Akagawa Y; Kimata T; Tsuji S
Front Immunol; 2020; 11():1616. PubMed ID: 32793240
[TBL] [Abstract][Full Text] [Related]
28. Self-assembling polymer-based short chain fatty acid prodrugs ameliorate non-alcoholic steatohepatitis and liver fibrosis.
Shashni B; Tajika Y; Ikeda Y; Nishikawa Y; Nagasaki Y
Biomaterials; 2023 Apr; 295():122047. PubMed ID: 36840994
[TBL] [Abstract][Full Text] [Related]
29. A High-Fat, High-Cholesterol Diet Promotes Intestinal Inflammation by Exacerbating Gut Microbiome Dysbiosis and Bile Acid Disorders in Cholecystectomy.
Xu F; Yu Z; Liu Y; Du T; Yu L; Tian F; Chen W; Zhai Q
Nutrients; 2023 Sep; 15(17):. PubMed ID: 37686860
[TBL] [Abstract][Full Text] [Related]
30. Short-chain fatty acids (SCFA) in infants' plasma and corresponding mother's milk and plasma in relation to subsequent sensitisation and atopic disease.
Barman M; Gio-Batta M; Andrieux L; Stråvik M; Saalman R; Fristedt R; Rabe H; Sandin A; Wold AE; Sandberg AS
EBioMedicine; 2024 Mar; 101():104999. PubMed ID: 38340558
[TBL] [Abstract][Full Text] [Related]
31. Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy.
Yadav SK; Ito K; Dhib-Jalbut S
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834203
[TBL] [Abstract][Full Text] [Related]
32. Lactulose regulates gut microbiota dysbiosis and promotes short-chain fatty acids production in acute pancreatitis patients with intestinal dysfunction.
Wang J; Jiang M; Hu Y; Lei Y; Zhu Y; Xiong H; He C
Biomed Pharmacother; 2023 Jul; 163():114769. PubMed ID: 37116350
[TBL] [Abstract][Full Text] [Related]
33. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
[TBL] [Abstract][Full Text] [Related]
34. The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology.
Buscarinu MC; Fornasiero A; Romano S; Ferraldeschi M; Mechelli R; Reniè R; Morena E; Romano C; Pellicciari G; Landi AC; Salvetti M; Ristori G
Front Immunol; 2019; 10():1916. PubMed ID: 31555257
[TBL] [Abstract][Full Text] [Related]
35. Dietary methionine restriction improves the gut microbiota and reduces intestinal permeability and inflammation in high-fat-fed mice.
Yang Y; Zhang Y; Xu Y; Luo T; Ge Y; Jiang Y; Shi Y; Sun J; Le G
Food Funct; 2019 Sep; 10(9):5952-5968. PubMed ID: 31475718
[TBL] [Abstract][Full Text] [Related]
36. The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity.
Holota Y; Dovbynchuk T; Kaji I; Vareniuk I; Dzyubenko N; Chervinska T; Zakordonets L; Stetska V; Ostapchenko L; Serhiychuk T; Tolstanova G
PLoS One; 2019; 14(8):e0220642. PubMed ID: 31437166
[TBL] [Abstract][Full Text] [Related]
37. Impact of short-chain fatty acid supplementation on gut inflammation and microbiota composition in a murine colitis model.
Lee JG; Lee J; Lee AR; Jo SV; Park CH; Han DS; Eun CS
J Nutr Biochem; 2022 Mar; 101():108926. PubMed ID: 34848335
[TBL] [Abstract][Full Text] [Related]
38. Intestinal Immune Dysregulation Driven by Dysbiosis Promotes Barrier Disruption and Bacterial Translocation in Rats With Cirrhosis.
Muñoz L; Borrero MJ; Úbeda M; Conde E; Del Campo R; Rodríguez-Serrano M; Lario M; Sánchez-Díaz AM; Pastor O; Díaz D; García-Bermejo L; Monserrat J; Álvarez-Mon M; Albillos A
Hepatology; 2019 Sep; 70(3):925-938. PubMed ID: 30414342
[TBL] [Abstract][Full Text] [Related]
39. Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation.
Ishizaka A; Koga M; Mizutani T; Parbie PK; Prawisuda D; Yusa N; Sedohara A; Kikuchi T; Ikeuchi K; Adachi E; Koibuchi T; Furukawa Y; Tojo A; Imoto S; Suzuki Y; Tsutsumi T; Kiyono H; Matano T; Yotsuyanagi H
Microbiol Spectr; 2021 Sep; 9(1):e0070821. PubMed ID: 34378948
[TBL] [Abstract][Full Text] [Related]
40. Sodium butyrate ameliorates diabetic retinopathy in mice via the regulation of gut microbiota and related short-chain fatty acids.
Huang Y; Wang Z; Ye B; Ma JH; Ji S; Sheng W; Ye S; Ou Y; Peng Y; Yang X; Chen J; Tang S
J Transl Med; 2023 Jul; 21(1):451. PubMed ID: 37420234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
